Objectives: Adult patients who have undergone the Fontan procedure are highly vulnerable to gradual, progressive circulatory failure, and options to reverse this situation are few. A cavopulmonary assist device could decongest the venous and lymphatic systems, overcome elevated pulmonary vascular resistance, increase cardiac output, and support some of these patients to heart transplant. This study characterizes the performance and challenges of a novel multilumen cannula coupled to an external blood pump proposed as a potential Fontan cavopulmonary assist strategy.
Methods: Computational fluid dynamic simulations were conducted for 3 extracardiac Fontan geometries consisting of 1 idealized model and 2 patient-specific models. A range of physiologic flow rates and pump assist levels were simulated to calculate the pressure gain provided by the multilumen cannula. Hemolysis index was estimated for the idealized model with Lagrangian particle tracking and 2 variations of the power-law. Wall shear stresses were also examined.
Results: Pressure gains up to 4 and 9 mm Hg were achieved for the idealized and patient-specific models, respectively. Pressure gains increased with both higher cardiac output and larger pump intake through the external pump. Flow-weighted hemolysis show hemoglobin damage levels to be several times lower than the 2% threshold at the highest pump intake flow cases. Wall shear stress predictions depict elevated areas in the pulmonary vessels and regions of the cannula device.
Conclusions: The cannula tested in this study shows promise as a percutaneous option to bridge support in some patients with a failing extracardiac Fontan. Limitations identified will be addressed in future design iterations and in ongoing experimental tests.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jtcvs.2019.03.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CFD-Based Hemolysis Study of Fontan Cavopulmonary Assist Device Using Kriging Surrogate Modeling.
Artif Organs
January 2025
Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Background: Predicting hemolysis numerically based on the power-law model using idealized coefficients obtained from simplified devices yields a large variability in hemolysis index predictions. A computational fluid dynamics (CFD)-based Kriging surrogate modeling approach, developed by Craven et al. at the US Food & Drug Administration (FDA), was applied to a Fontan cavopulmonary assist device (CPAD) to generate device-specific hemolysis power-law coefficients.
View Article and Find Full Text PDFAutonomous Fontan pump: Computational feasibility study.
JTCVS Open
October 2024
Mechanical Solutions Inc, Whippany, NJ.
Objective: After Fontan palliation, patients with single-ventricle physiology are committed to chronic circulatory inefficiency for the duration of their lives. This is due in large part to the lack of a subpulmonary ventricle. A low-pressure rise cavopulmonary assist device can address the subpulmonary deficit and offset the Fontan paradox.
View Article and Find Full Text PDFIncidence, pathophysiology, and treatment of failing Fontan after the total cavopulmonary connection.
Cardiol Young
October 2024
Department of Congenital and Pediatric Heart Surgery, Technische Universität München, German Heart Center Munich, Munich, Germany.
Article Synopsis
- This study investigates the challenging condition known as failing Fontan in patients who have undergone total cavopulmonary connection, focusing on its incidence, causes, risk factors, and treatment options.
- Out of 634 patients analyzed from 1994 to 2022, 76 were diagnosed with failing Fontan, resulting in an incidence rate of 1.48 per 100 patient-years, and key symptoms included protein-losing enteropathy and hospital readmissions.
- Key risk factors for developing failing Fontan include having a dominant right ventricle and elevated pulmonary artery pressure prior to surgery, while patients showed a survival rate of 77% ten years after failure onset; zlog-
A cavalpulmonary assist device utilising impedance pumping enhanced by peristaltic effect.
Int J Artif Organs
October 2024
Department of Engineering, Durham University, Durham, UK.
Background: Fontan procedure, the standard surgical palliation to treat children with single ventricular defects, causes systemic complications over years due to lack of pumping at cavopulmonary junction. A device developed specifically for cavopulmonary support is thus considered, while current commercial ventricular assist devices (VAD) induce high shear rates to blood, and have issues with paediatric suitability.
Aim: To demonstrate the feasibility of a small, valveless, non-invasive to blood and pulsatile rotary pump, which integrates impedance and peristaltic effects.
Current Understanding and Future Directions of Transcatheter Devices to Assist Failing Fontan.
J Soc Cardiovasc Angiogr Interv
April 2024
Cardiac Surgery Unit, Heart Transplant and MCS Program, Cardio-thoracic-vascular and Public Health Department, Padova University Hospital, Padova, Italy.
Article Synopsis
- The Fontan operation is the preferred surgical treatment for patients with univentricular physiology, but it is only a temporary solution that leads to complications as they reach adulthood.
- These patients often face severe health issues, such as liver failure and arrhythmias, and heart transplantation is the ideal treatment, although it is frequently delayed and complicated by donor shortages.
- Mechanical circulatory support options are emerging as potential solutions, with ongoing research into intravascular pumps, but they currently require high-risk surgeries and are still experimental.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!